{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:00:57Z","timestamp":1777654857950,"version":"3.51.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T00:00:00Z","timestamp":1266278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10549-010-0757-7","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T05:05:46Z","timestamp":1266210346000},"page":"525-538","source":"Crossref","is-referenced-by-count":65,"title":["Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?"],"prefix":"10.1007","volume":"120","author":[{"given":"Omar S.","family":"Din","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,16]]},"reference":[{"issue":"9472","key":"757_CR1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTCG","year":"2005","unstructured":"EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717","journal-title":"Lancet"},{"issue":"22","key":"757_CR2","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1200\/JCO.2000.18.22.3748","volume":"18","author":"J Bonneterre","year":"2000","unstructured":"Bonneterre J et al (2000) Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study. J Clin Oncol 18(22):3748\u20133757","journal-title":"J Clin Oncol"},{"issue":"11","key":"757_CR3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2003.04.194","volume":"21","author":"H Mouridsen","year":"2003","unstructured":"Mouridsen H et al (2003) Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol 21(11):2101\u20132109","journal-title":"J Clin Oncol"},{"issue":"22","key":"757_CR4","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1200\/JCO.2000.18.22.3758","volume":"18","author":"JM Nabholtz","year":"2000","unstructured":"Nabholtz JM et al (2000) Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol 18(22):3758\u20133767","journal-title":"J Clin Oncol"},{"issue":"9453","key":"757_CR5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A et al (2005) Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for breast cancer. Lancet 365(9453):60\u201362","journal-title":"Lancet"},{"issue":"19","key":"757_CR6","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","volume":"349","author":"PE Goss","year":"2003","unstructured":"Goss PE et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349(19):1793\u20131802","journal-title":"N Engl J Med"},{"issue":"11","key":"757_CR7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","volume":"350","author":"RC Coombes","year":"2004","unstructured":"Coombes RC et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350(11):1081\u20131092","journal-title":"N Engl J Med"},{"issue":"9561","key":"757_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","volume":"369","author":"RC Coombes","year":"2007","unstructured":"Coombes RC et al (2007) Survival and safety of exemestane versus tamoxifen after 2\u20133\u00a0years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 369(9561):559\u2013570","journal-title":"Lancet"},{"issue":"9484","key":"757_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"R Jakesz","year":"2005","unstructured":"Jakesz R et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2\u00a0years\u2019 adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455\u2013462","journal-title":"Lancet"},{"issue":"26","key":"757_CR10","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"B Thurlimann","year":"2005","unstructured":"Thurlimann B et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26):2747\u20132757","journal-title":"N Engl J Med"},{"key":"757_CR11","doi-asserted-by":"crossref","unstructured":"Boccardo F et al (2006) Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol 17(7): vii10\u20134","DOI":"10.1093\/annonc\/mdl941"},{"issue":"3","key":"757_CR12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra050776","volume":"354","author":"JD Yager","year":"2006","unstructured":"Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354(3):270\u2013282","journal-title":"N Engl J Med"},{"issue":"2","key":"757_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003495-199958020-00003","volume":"58","author":"VC Njar","year":"1999","unstructured":"Njar VC, Brodie AM (1999) Comprehensive pharmacology and clinical efficacy of aromatase inhibitors. Drugs 58(2):233\u2013255","journal-title":"Drugs"},{"issue":"2","key":"757_CR14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.9-2-126","volume":"9","author":"SM Campos","year":"2004","unstructured":"Campos SM (2004) Aromatase inhibitors for breast cancer in postmenopausal women. Oncologist 9(2):126\u2013136","journal-title":"Oncologist"},{"issue":"1\u20133","key":"757_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0960-0760(92)90198-R","volume":"43","author":"E Salle di","year":"1992","unstructured":"di Salle E et al (1992) Exemestane (FCE 24304), a new steroidal aromatase inhibitor. J Steroid Biochem Mol Biol 43(1\u20133):137\u2013143","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9152","key":"757_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(98)05352-5","volume":"353","author":"GA Greendale","year":"1999","unstructured":"Greendale GA, Lee NP, Arriola ER (1999) The menopause. Lancet 353(9152):571\u2013580","journal-title":"Lancet"},{"key":"757_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jama.1925.02660280001001","volume":"84","author":"RL Cecil","year":"1925","unstructured":"Cecil RL, Archer BH (1925) Arthritis of the menopause. JAMA 84:75\u201379","journal-title":"JAMA"},{"key":"757_CR18","unstructured":"Avis N et al (2004) Baillere\u2019s clinical endocrinology and metabolism. In: Burger H (ed) The evolution of menopausal symptoms. Bailliere Tindall, London"},{"issue":"4","key":"757_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.ajp.0000208249.07949.d5","volume":"22","author":"SA Dugan","year":"2006","unstructured":"Dugan SA et al (2006) Musculoskeletal pain and menopausal status. Clin J Pain 22(4):325\u2013331","journal-title":"Clin J Pain"},{"issue":"5","key":"757_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3122\/jabfm.18.5.374","volume":"18","author":"J Xu","year":"2005","unstructured":"Xu J et al (2005) Natural history of menopause symptoms in primary care patients: a MetroNet study. J Am Board Fam Pract 18(5):374\u2013382","journal-title":"J Am Board Fam Pract"},{"issue":"1","key":"757_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13697130701746006","volume":"11","author":"CE Szoeke","year":"2008","unstructured":"Szoeke CE et al (2008) The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study. Climacteric 11(1):55\u201362","journal-title":"Climacteric"},{"issue":"5","key":"757_CR22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.ijo.0800411","volume":"21","author":"C Huang","year":"1997","unstructured":"Huang C et al (1997) Factors associated with joint pain among postmenopausal women. Int J Obes Relat Metab Disord 21(5):349\u2013354","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 2","key":"757_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000227750","volume":"54","author":"M Dowsett","year":"1997","unstructured":"Dowsett M, Lonning PE (1997) Anastrozole\u2013a new generation in aromatase inhibition: clinical pharmacology. Oncology 54(Suppl 2):11\u201314","journal-title":"Oncology"},{"issue":"1","key":"757_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2008.03594.x","volume":"152","author":"RH Nielsen","year":"2008","unstructured":"Nielsen RH et al (2008) Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats. Clin Exp Immunol 152(1):21\u201327","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"757_CR25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4049\/jimmunol.180.1.630","volume":"180","author":"A Cvoro","year":"2008","unstructured":"Cvoro A et al (2008) Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. J Immunol 180(1):630\u2013636","journal-title":"J Immunol"},{"issue":"1","key":"757_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(97)00092-9","volume":"757","author":"M Dawson-Basoa","year":"1997","unstructured":"Dawson-Basoa M, Gintzler AR (1997) Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res 757(1):37\u201342","journal-title":"Brain Res"},{"issue":"3","key":"757_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-3959(98)00258-9","volume":"81","author":"JL Riley 3rd","year":"1999","unstructured":"Riley JL 3rd et al (1999) A meta-analytic review of pain perception across the menstrual cycle. Pain 81(3):225\u2013235","journal-title":"Pain"},{"issue":"7","key":"757_CR28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jsgi.2006.07.002","volume":"13","author":"W Dietrich","year":"2006","unstructured":"Dietrich W et al (2006) Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. J Soc Gynecol Investig 13(7):512\u2013517","journal-title":"J Soc Gynecol Investig"},{"issue":"3","key":"757_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ctrv.2007.10.004","volume":"34","author":"RE Coleman","year":"2008","unstructured":"Coleman RE et al (2008) Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations. Cancer Treat Rev 34(3):275\u2013282","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"757_CR30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1297-319X(03)00067-8","volume":"70","author":"P Richette","year":"2003","unstructured":"Richette P, Corvol M, Bardin T (2003) Estrogens, cartilage, and osteoarthritis. Joint Bone Spine 70(4):257\u2013262","journal-title":"Joint Bone Spine"},{"issue":"5","key":"757_CR31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.joca.2008.01.002","volume":"16","author":"YH Sniekers","year":"2008","unstructured":"Sniekers YH et al (2008) Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment\u2014a systematic approach. Osteoarthr Cartil 16(5):533\u2013541","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"757_CR32","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/art.22009","volume":"54","author":"S Oestergaard","year":"2006","unstructured":"Oestergaard S et al (2006) Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Arthritis Rheum 54(8):2441\u20132451","journal-title":"Arthritis Rheum"},{"issue":"4","key":"757_CR33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/1529-0131(200104)44:4<811::AID-ANR137>3.0.CO;2-F","volume":"44","author":"MC Nevitt","year":"2001","unstructured":"Nevitt MC et al (2001) The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen\/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 44(4):811\u2013818","journal-title":"Arthritis Rheum"},{"issue":"10","key":"757_CR34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0039-128X(01)00104-0","volume":"66","author":"J Bail Le","year":"2001","unstructured":"Le Bail J et al (2001) Aromatase in synovial cells from postmenopausal women. Steroids 66(10):749\u2013757","journal-title":"Steroids"},{"issue":"9","key":"757_CR35","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1359\/jbmr.1997.12.9.1416","volume":"12","author":"H Sasano","year":"1997","unstructured":"Sasano H et al (1997) Aromatase in human bone tissue. J Bone Miner Res 12(9):1416\u20131423","journal-title":"J Bone Miner Res"},{"issue":"1","key":"757_CR36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cellbi.2007.08.014","volume":"32","author":"A Toesca","year":"2008","unstructured":"Toesca A et al (2008) Estrogen and progesterone receptors in carpal tunnel syndrome. Cell Biol Int 32(1):75\u201379","journal-title":"Cell Biol Int"},{"issue":"4","key":"757_CR37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.2006.066159","volume":"66","author":"B Morel","year":"2007","unstructured":"Morel B, Marotte H, Miossec P (2007) Will steroidal aromatase inhibitors induce rheumatoid arthritis? Ann Rheum Dis 66(4):557\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"757_CR38","first-page":"2259","volume":"34","author":"M Laroche","year":"2007","unstructured":"Laroche M et al (2007) Joint pain with aromatase inhibitors: abnormal frequency of Sjogren\u2019s syndrome. J Rheumatol 34(11):2259\u20132263","journal-title":"J Rheumatol"},{"issue":"2","key":"757_CR39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","volume":"111","author":"NL Henry","year":"2008","unstructured":"Henry NL et al (2008) Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 111(2):365\u2013372","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"757_CR40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","volume":"23","author":"J Pfeilschifter","year":"2002","unstructured":"Pfeilschifter J et al (2002) Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23(1):90\u2013119","journal-title":"Endocr Rev"},{"issue":"16","key":"757_CR41","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.24419","volume":"115","author":"JJ Mao","year":"2009","unstructured":"Mao JJ et al (2009) Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115(16):3631\u20133639","journal-title":"Cancer"},{"issue":"9","key":"757_CR42","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1470-2045(08)70182-7","volume":"9","author":"I Sestak","year":"2008","unstructured":"Sestak I et al (2008) Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. Lancet Oncol 9(9):866\u2013872","journal-title":"Lancet Oncol"},{"key":"757_CR43","doi-asserted-by":"crossref","unstructured":"Buzdar A (2006) Clinical features of joint symptoms observed in the \u2018Arimidex\u2019, Tamoxifen, Alone or in Combination (ATAC) trial. J Clin Oncol 24(18S): 551","DOI":"10.1200\/jco.2006.24.18_suppl.551"},{"issue":"8","key":"757_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(06)70767-7","volume":"7","author":"A Buzdar","year":"2006","unstructured":"Buzdar A et al (2006) Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 7(8):633\u2013643","journal-title":"Lancet Oncol"},{"issue":"21","key":"757_CR45","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","volume":"22","author":"L Fallowfield","year":"2004","unstructured":"Fallowfield L et al (2004) Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J Clin Oncol 22(21):4261\u20134271","journal-title":"J Clin Oncol"},{"issue":"3","key":"757_CR46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","volume":"100","author":"D Cella","year":"2006","unstructured":"Cella D et al (2006) Quality of life of postmenopausal women in the ATAC (\u201cArimidex\u201d, tamoxifen, alone or in combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for early breast cancer. Breast Cancer Res Treat 100(3):273\u2013284","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"757_CR47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.breast.2007.07.034","volume":"17","author":"S Khanduri","year":"2007","unstructured":"Khanduri S, Dodwell DJ (2007) Aromatase inhibitors and musculoskeletal symptoms. Breast 17(1):76\u201379","journal-title":"Breast"},{"issue":"12","key":"757_CR48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","volume":"9","author":"J Cuzick","year":"2008","unstructured":"Cuzick J et al (2008) Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 9(12):1143\u20131148","journal-title":"Lancet Oncol"},{"issue":"3","key":"757_CR49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncponc1043","volume":"5","author":"L Fallowfield","year":"2008","unstructured":"Fallowfield L (2008) There\u2019s many a slip twixt cup and lip: adherence issues in cancer therapy. Nat Clin Pract Oncol 5(3):118\u2013119","journal-title":"Nat Clin Pract Oncol"},{"issue":"1\u20132","key":"757_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000100444","volume":"71","author":"RT Chlebowski","year":"2006","unstructured":"Chlebowski RT, Geller ML (2006) Adherence to endocrine therapy for breast cancer. Oncology 71(1\u20132):1\u20139","journal-title":"Oncology"},{"issue":"6","key":"757_CR51","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2005.03.3654","volume":"24","author":"LJ Fallowfield","year":"2006","unstructured":"Fallowfield LJ et al (2006) Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3\u00a0years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24(6):910\u2013917","journal-title":"J Clin Oncol"},{"issue":"28","key":"757_CR52","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","volume":"23","author":"TJ Whelan","year":"2005","unstructured":"Whelan TJ et al (2005) Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5\u00a0years of tamoxifen in postmenopausal women. J Clin Oncol 23(28):6931\u20136940","journal-title":"J Clin Oncol"},{"issue":"1","key":"757_CR53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/ar2369","volume":"10","author":"DT Felson","year":"2008","unstructured":"Felson DT (2008) Comparing the prevalence of rheumatic diseases in China with the rest of the world. Arthritis Res Ther 10(1):106","journal-title":"Arthritis Res Ther"},{"issue":"25","key":"757_CR54","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","volume":"25","author":"KD Crew","year":"2007","unstructured":"Crew KD et al (2007) Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 25(25):3877\u20133883","journal-title":"J Clin Oncol"},{"issue":"10","key":"757_CR55","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3816\/CBC.2007.n.038","volume":"7","author":"CA Presant","year":"2007","unstructured":"Presant CA et al (2007) Aromatase inhibitor-associated arthralgia and\/or bone pain: frequency and characterization in non-clinical trial patients. Clin Breast Cancer 7(10):775\u2013778","journal-title":"Clin Breast Cancer"},{"key":"757_CR56","unstructured":"Dent SF et al (2007) Adjuvant aromatse inhibitors in early breast cancer\u2014toxicity and adherence. Important observations in clinical practice. In: San Antonio breast cancer symposium. San Antonio, Texas"},{"key":"757_CR57","unstructured":"Renshaw L et al (2007) Comparison of joint problems as reported by patients in a randomised adjuvant trial of anastrozole and letrozole. In: San Antonio breast caner symposium, p 2072"},{"issue":"1","key":"757_CR58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-006-9394-6","volume":"104","author":"L Morales","year":"2007","unstructured":"Morales L et al (2007) Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 104(1):87\u201391","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"757_CR59","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1200\/JCO.2007.15.4005","volume":"26","author":"L Morales","year":"2008","unstructured":"Morales L et al (2008) Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 26(19):3147\u20133152","journal-title":"J Clin Oncol"},{"key":"757_CR60","unstructured":"Alegre-Sancho JJ et al (2008) Trigger thumb in patients with breast cancer and hand pain associated with aromatase inhibitors. Ann Rheum Dis 67(Suppl II)"},{"issue":"30","key":"757_CR61","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1200\/JCO.2008.20.5435","volume":"27","author":"O Dizdar","year":"2009","unstructured":"Dizdar O et al (2009) Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol 27(30):4955\u20134960","journal-title":"J Clin Oncol"},{"issue":"30","key":"757_CR62","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2009.22.0236","volume":"27","author":"I Sestak","year":"2009","unstructured":"Sestak I, Sapunar F, Cuzick J (2009) Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. J Clin Oncol 27(30):4961\u20134965","journal-title":"J Clin Oncol"},{"key":"757_CR63","unstructured":"Sestak I, Cuzick J (2007) Risk factors for joint symptoms in the ATAC trial. In: San Antonio breast caner symposium, p 2071"},{"key":"757_CR64","unstructured":"Singh S, Howell A, Cuzick J (2006) Vit D levels among patients with arthralgia: results from IBIS-II breast cancer prevention study. In: San Antonio breast caner symposium, p 1068"},{"key":"757_CR65","unstructured":"Azria D et al (2007) Letrozole induced arthralgia: results of a multicentric prospective trial exploring clinical parameters and plasma biomarkers. In: ASCO breast cancer symposium, p 228"},{"issue":"1","key":"757_CR66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-009-0495-x","volume":"119","author":"QJ Khan","year":"2010","unstructured":"Khan QJ et al (2010) Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 119(1):111\u2013118","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"757_CR67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1534735409332903","volume":"8","author":"JJ Mao","year":"2009","unstructured":"Mao JJ et al (2009) Feasibility trial of electroacupuncture for aromatase inhibitor-related arthralgia in breast cancer survivors. Integr Cancer Ther 8(2):123\u2013129","journal-title":"Integr Cancer Ther"},{"key":"757_CR68","doi-asserted-by":"crossref","unstructured":"Crew KD et al (2009) Randomized, blinded, placebo-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 27(15s): 571","DOI":"10.1200\/jco.2009.27.15_suppl.571"},{"issue":"11","key":"757_CR69","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7(11):903\u2013909","journal-title":"Lancet Oncol"},{"issue":"19","key":"757_CR70","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2008.16.7684","volume":"26","author":"DL Hershman","year":"2008","unstructured":"Hershman DL (2008) Getting a grip on aromatase inhibitor-associated arthralgias. J Clin Oncol 26(19):3120\u20133121","journal-title":"J Clin Oncol"},{"issue":"7","key":"757_CR71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.joca.2007.01.012","volume":"15","author":"KD Allen","year":"2007","unstructured":"Allen KD et al (2007) Validity and factor structure of the AUSCAN Osteoarthritis Hand Index in a community-based sample. Osteoarthr Cartil 15(7):830\u2013836","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"757_CR72","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/rheumatology\/keh360","volume":"43","author":"J Sautner","year":"2004","unstructured":"Sautner J et al (2004) Development of the M-SACRAH, a modified, shortened version of SACRAH (Score for the Assessment and Quantification of Chronic Rheumatoid Affections of the Hands). Rheumatology 43(11):1409\u20131413","journal-title":"Rheumatology"},{"key":"757_CR73","doi-asserted-by":"crossref","unstructured":"Sautner J et al (2009) A comparison of the Modified Score for the Assessment of Chronic Rheumatoid Affections of the Hands and the Australian\/Canadian Osteoarthritis Hand Index in Hand Osteoarthritis Patients. Int J Rheumatol 1\u20137","DOI":"10.1155\/2009\/249096"},{"issue":"4","key":"757_CR74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0894-1130(12)80326-7","volume":"6","author":"R Harkonen","year":"1993","unstructured":"Harkonen R, Harju R, Alaranta H (1993) Accuracy of the Jamar dynamometer. J Hand Ther 6(4):259\u2013262","journal-title":"J Hand Ther"},{"issue":"2","key":"757_CR75","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0363-5023(84)80146-X","volume":"9","author":"V Mathiowetz","year":"1984","unstructured":"Mathiowetz V et al (1984) Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am 9(2):222\u2013226","journal-title":"J Hand Surg Am"},{"issue":"7","key":"757_CR76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/ard.60.7.641","volume":"60","author":"M Backhaus","year":"2001","unstructured":"Backhaus M et al (2001) Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 60(7):641\u2013649","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"757_CR77","first-page":"2485","volume":"32","author":"RJ Wakefield","year":"2005","unstructured":"Wakefield RJ et al (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32(12):2485\u20132487","journal-title":"J Rheumatol"},{"key":"757_CR78","doi-asserted-by":"crossref","unstructured":"Schmidt WA (2007) Technology insight: the role of color and power Doppler ultrasonography in rheumatology. Nat Clin Pract Rheumatol. 3(1): 35\u201342 (quiz 59)","DOI":"10.1038\/ncprheum0377"},{"issue":"9","key":"757_CR79","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1470-2045(08)70217-1","volume":"9","author":"AL Tan","year":"2008","unstructured":"Tan AL, Emery P (2008) Role of oestrogen in the development of joint symptoms? Lancet Oncol 9(9):817\u2013818","journal-title":"Lancet Oncol"},{"issue":"3","key":"757_CR80","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1521-6942(03)00021-4","volume":"17","author":"AL Tan","year":"2003","unstructured":"Tan AL et al (2003) Imaging of the musculoskeletal system: magnetic resonance imaging, ultrasonography and computed tomography. Best Pract Res Clin Rheumatol 17(3):513\u2013528","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"757_CR81","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/ard.2006.068361","volume":"66","author":"EA Haavardsholm","year":"2007","unstructured":"Haavardsholm EA et al (2007) Introduction of a novel magnetic resonance imaging tenosynovitis score for rheumatoid arthritis: reliability in a multireader longitudinal study. Ann Rheum Dis 66(9):1216\u20131220","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"757_CR82","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/art.21493","volume":"52","author":"EA Haavardsholm","year":"2005","unstructured":"Haavardsholm EA et al (2005) Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting. Arthritis Rheum 52(12):3860\u20133867","journal-title":"Arthritis Rheum"},{"issue":"19","key":"757_CR83","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1158\/1078-0432.CCR-07-5101","volume":"14","author":"JE Lester","year":"2008","unstructured":"Lester JE et al (2008) Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clin Cancer Res 14(19):6336\u20136342","journal-title":"Clin Cancer Res"},{"issue":"5","key":"757_CR84","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1634\/theoncologist.2007-0206","volume":"13","author":"A Brufsky","year":"2008","unstructured":"Brufsky A et al (2008) Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole. Oncologist 13(5):503\u2013514","journal-title":"Oncologist"},{"issue":"30","key":"757_CR85","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","volume":"26","author":"GK Ellis","year":"2008","unstructured":"Ellis GK et al (2008) Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol 26(30):4875\u20134882","journal-title":"J Clin Oncol"},{"issue":"6","key":"757_CR86","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2005.043869","volume":"65","author":"G Haugeberg","year":"2006","unstructured":"Haugeberg G et al (2006) Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 65(6):736\u2013740","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"757_CR87","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/ard.2006.067652","volume":"66","author":"G Haugeberg","year":"2007","unstructured":"Haugeberg G et al (2007) Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Ann Rheum Dis 66(11):1513\u20131517","journal-title":"Ann Rheum Dis"},{"key":"757_CR88","doi-asserted-by":"crossref","unstructured":"Henry NL et al (2008) A distinct inflammatory marker pattern in patients with aromatase inhibitor (AI)-induced musculoskeletal symptoms. In: SABCS. San Antonio, Texas","DOI":"10.1158\/0008-5472.SABCS-1129"},{"issue":"5","key":"757_CR89","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar2314","volume":"9","author":"DJ Hunter","year":"2007","unstructured":"Hunter DJ et al (2007) Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther 9(5):R108","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"757_CR90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar2344","volume":"10","author":"FM Williams","year":"2008","unstructured":"Williams FM, Spector TD (2008) Biomarkers in osteoarthritis. Arthritis Res Ther 10(1):101","journal-title":"Arthritis Res Ther"},{"key":"757_CR91","first-page":"8","volume":"80","author":"R Landewe","year":"2007","unstructured":"Landewe R (2007) Predictive markers in rapidly progressing rheumatoid arthritis. J Rheumatol Suppl 80:8\u201315","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"757_CR92","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13547500701669410","volume":"13","author":"N Wild","year":"2008","unstructured":"Wild N et al (2008) Diagnosis of rheumatoid arthritis: multivariate analysis of biomarkers. Biomarkers 13(1):88\u2013105","journal-title":"Biomarkers"},{"key":"757_CR93","unstructured":"ClinicalTrials.gov. 2009 7th July 2009]; Available from: http:\/\/clinicaltrials.gov\/ct2\/results?term=breast+cancer+AND+arthralgia"},{"issue":"24","key":"757_CR94","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jnci\/djm246","volume":"99","author":"R Jakesz","year":"2007","unstructured":"Jakesz R et al (2007) Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a. J Natl Cancer Inst 99(24):1845\u20131853","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"757_CR95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.breast.2007.01.011","volume":"16","author":"HJ Burstein","year":"2007","unstructured":"Burstein HJ (2007) Aromatase inhibitor-associated arthralgia syndrome. Breast 16(3):223\u2013234","journal-title":"Breast"},{"key":"757_CR96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jus.2007.03.002","volume":"10","author":"S Bianchi","year":"2007","unstructured":"Bianchi S et al. (2007) Ultrasound of the digital flexor system: normal and pathological findings. J Ultrasound 10:85\u201392","journal-title":"J Ultrasound"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0757-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0757-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0757-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T07:18:12Z","timestamp":1685431092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0757-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,16]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0757-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,16]]}}}